These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19773553)

  • 21. Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.
    Regenold WT; Blumenthal JB; Loreck DJ; Mordecai KL; Scarinzi G; Doddi SR; Adler L
    Am J Alzheimers Dis Other Demen; 2017 Sep; 32(6):347-352. PubMed ID: 28449585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme.
    Eckman EA; Adams SK; Troendle FJ; Stodola BA; Kahn MA; Fauq AH; Xiao HD; Bernstein KE; Eckman CB
    J Biol Chem; 2006 Oct; 281(41):30471-8. PubMed ID: 16912050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease.
    Hemming ML; Selkoe DJ; Farris W
    Neurobiol Dis; 2007 Apr; 26(1):273-81. PubMed ID: 17321748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme.
    Araujo MC; Melo RL; Cesari MH; Juliano MA; Juliano L; Carmona AK
    Biochemistry; 2000 Jul; 39(29):8519-25. PubMed ID: 10913258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice.
    Elased KM; Cunha TS; Marcondes FK; Morris M
    Exp Physiol; 2008 May; 93(5):665-75. PubMed ID: 18263657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
    Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
    J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
    Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
    Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.
    Lupi R; Del Guerra S; Bugliani M; Boggi U; Mosca F; Torri S; Del Prato S; Marchetti P
    Eur J Endocrinol; 2006 Feb; 154(2):355-61. PubMed ID: 16452552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine epitope mapping of monoclonal antibody 5F1 reveals anticatalytic activity toward the N domain of human angiotensin-converting enzyme.
    Danilov SM; Watermeyer JM; Balyasnikova IV; Gordon K; Kugaevskaya EV; Elisseeva YE; Albrecht RF; Sturrock ED
    Biochemistry; 2007 Aug; 46(31):9019-31. PubMed ID: 17630779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
    Hiwada K; Inoue Y; Kokubu T
    Gen Pharmacol; 1990; 21(4):555-8. PubMed ID: 2165961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
    Michaud A; Williams TA; Chauvet MT; Corvol P
    Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides.
    Cotton J; Hayashi MA; Cuniasse P; Vazeux G; Ianzer D; De Camargo AC; Dive V
    Biochemistry; 2002 May; 41(19):6065-71. PubMed ID: 11994001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.
    Binevski PV; Sizova EA; Pozdnev VF; Kost OA
    FEBS Lett; 2003 Aug; 550(1-3):84-8. PubMed ID: 12935891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease.
    Kugaevskaya EV; Veselovsky AV; Indeykina MI; Solovyeva NI; Zharkova MS; Popov IA; Nikolaev EN; Mantsyzov AB; Makarov AA; Kozin SA
    Sci Rep; 2018 Jan; 8(1):298. PubMed ID: 29321566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.
    Rocha NP; Toledo A; Corgosinho LTS; de Souza LC; Guimarães HC; Resende EPF; Braz NFT; Gomes KB; Simoes E Silva AC; Caramelli P; Teixeira AL
    J Alzheimers Dis; 2018; 64(4):1085-1090. PubMed ID: 30040721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical characterization of the gamma-secretase activity that produces beta-amyloid peptides.
    Zhang L; Song L; Terracina G; Liu Y; Pramanik B; Parker E
    Biochemistry; 2001 Apr; 40(16):5049-55. PubMed ID: 11305921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiotensin converting enzyme: the antigenic properties of the domain, role in Alzheimer's disease and tumor progression].
    Kugaevskaya EV; Timoshenko OS; Solovyeva NI
    Biomed Khim; 2015; 61(3):301-11. PubMed ID: 26215407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.
    Beach TG; Maarouf CL; Intorcia A; Sue LI; Serrano GE; Lu M; Joshi A; Pontecorvo MJ; Roher AE
    J Alzheimers Dis; 2018; 61(4):1509-1516. PubMed ID: 29376867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct Uptake Kinetics of Alzheimer Disease Amyloid-
    Sharda N; Ahlschwede KM; Curran GL; Lowe VJ; Kandimalla KK
    J Pharmacol Exp Ther; 2021 Mar; 376(3):482-490. PubMed ID: 33303699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
    Dong M; Zhao W; Hu D; Ai H; Kang B
    ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.